Biology Reference
In-Depth Information
containing different types of strand breaks.
J Biol Chem
1980;
255(21):10502
45. KimMY, Mauro S, Gevry N, Lis JT, Kraus WL. NAD
-dependent
modulation of chromatin structure and transcription by nucleo-
some binding properties of PARP-1.
Cell
2004;119(6):803
รพ
8.
29. Haince JF, McDonald D, Rodrigue A, Dery U, Masson JY,
Hendzel MJ, et al. PARP1-dependent kinetics of recruitment of
MRE11 and NBS1 proteins to multiple DNA damage sites.
J Biol
Chem
2008;283(2):1197
e
14.
46. Lonskaya I, Potaman VN, Shlyakhtenko LS, Oussatcheva EA,
Lyubchenko YL, Soldatenkov VA. Regulation of poly(ADP-
ribose) polymerase-1 by DNA structure-specific binding.
J Biol
Chem
2005;280(17):17076
e
208.
30. Boulton S, Kyle S, Durkacz BW. Interactive effects of inhibitors of
poly(ADP-ribose) polymerase and DNA-dependent protein
kinase on cellular responses to DNA damage.
Carcinogenesis
1999;20(2):199
e
83.
47. Hassa PO, Hottiger MO. A role of poly (ADP-ribose) polymerase
in NF-kappaB transcriptional activation.
Biol Chem
1999;380
(7-8):953
e
9.
48. Caiafa P, Guastafierro T, Zampieri M. Epigenetics: poly(ADP-
ribosyl)ation of PARP-1 regulates genomic methylation patterns.
FASEB J
2009;23(3):672
e
203.
31. Ruscetti T, Lehnert BE, Halbrook J, Le Trong H, Hoekstra MF,
Chen DJ, et al. Stimulation of the DNA-dependent protein
kinase by poly(ADP-ribose) polymerase.
J Biol Chem
1998;273(23):
14461
e
8.
49. Purnell MR, Whish WJD. Novel inhibitors of poly(ADP-ribose)
synthetase.
Biochem J
1980;185:775
e
7.
32. Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW.
Radiosensitization and DNA repair inhibition by the combined
use of novel inhibitors of DNA-dependent protein kinase and
poly(ADP-ribose) polymerase-1.
Cancer Res
2003;63(18):6008
e
7.
50. Durkacz B, Omidiji O, Gray D, Shall S. (ADP-ribose)
n
participates
in DNA excision repair.
Nature
1980;283:593
e
6.
51. Ben-Hur E, Chen CC, Elkind MM. Inhibitors of poly(adenosine
diphosphoribose) synthetase, examination of metabolic pertur-
bations, and enhancement of radiation response in Chinese
hamster cells.
Cancer Res
1985;45(5):2123
e
15.
33. Veuger SJ, Curtin NJ, Smith GC, Durkacz BW. Effects of novel
inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-
dependent protein kinase on enzyme activities and DNA repair.
Oncogene
2004;23(44):7322
e
7.
52. Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM, Sebolt-
Leopold JS. Dihydroisoquinolinones: the design and synthesis of
a new series of potent inhibitors of poly(ADP-ribose) polymerase.
Anticancer Drug Des
1991;6(2):107
e
9.
34. Audebert M, Salles B, Weinfeld M, Calsou P. Involvement of
polynucleotide kinase in a poly(ADP-ribose) polymerase-1-
dependent DNA double-strand breaks rejoining pathway.
J Mol
Biol
2006;356(2):257
e
17.
53. Bowman KJ, White A, Golding BT, Griffin RJ, Curtin NJ. Poten-
tiation of anti-cancer agent cytotoxicity by the potent poly(ADP-
ribose) polymerase inhibitors NU1025 and NU1064.
Br J Cancer
1998;78(10):1269
e
65.
35. Wang M, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. PARP-1
and Ku compete for repair of DNA double strand breaks by
distinct NHEJ pathways.
Nucleic Acids Res
2006;34(21):6170
e
77.
54. White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ,
Hostomsky Z, et al. Resistance-modifying agents. 9. Synthesis
and biological properties of benzimidazole inhibitors of the DNA
repair enzyme poly(ADP-ribose) polymerase.
J Med Chem
2000;
43(22):4084
e
82.
36. Mitchell J, Smith GC, Curtin NJ. Poly(ADP-Ribose) polymerase-1
and DNA-dependent protein kinase have equivalent roles in
double strand break repair following ionizing radiation.
Int J
Radiat Oncol Biol Phys
2009;75(5):1520
e
7.
37. Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D,
Schweiger M, et al. Mice lacking ADPRT and poly(ADP-ribosyl)
ation develop normally but are susceptible to skin disease.
Genes
Develop
1995;9:509
e
97.
55. Arundel-Suto CM, Scavone SV, Turner WR, Suto MJ, Sebolt-
Leopold JS. Effect of PD 128763, a new potent inhibitor of
poly(ADP-ribose) polymerase, on X-ray-induced cellular
recovery processes in Chinese hamster V79 cells.
Radiat Res
1991;
126(3):367
e
20.
38. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B,
Mark M, et al. Requirement of poly(ADP-ribose) polymerase in
recovery from DNA damage in mice and in cells.
Proc Natl Acad
Sci USA
1997 Jul 8;94(14):7303
e
71.
56. Banasik B, Komura H, Shimoyama M, Ueda K. Specific inhibitors
of poly(ADP-ribose) synthetase and mono(ADP-ribosyl) trans-
ferase.
J Biol Chem
1992;267:1569
e
7.
39. Masutani M, Nozaki T, Nishiyama E, Shimokawa T, Tachi Y,
Suzuki H, et al. Function of poly(ADP-ribose) polymerase in
response to DNA damage: gene-disruption study in mice.
Mol
Cell Biochem
1999;193(1-2):149
e
75.
57. Canan Koch SS, Thoresen LH, Tikhe JG, Maegley KA,
Almassy RJ, Li J, et al. Novel tricyclic poly(ADP-ribose) poly-
merase-1 inhibitors with potent anticancer chemopotentiating
activity: design, synthesis, and X-ray cocrystal structure.
JMed
Chem
2002;45(23):4961
e
52.
40. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW,
Jacobson MK, et al. Poly(ADP-ribose) polymerase null mouse
cells synthesize ADP-ribose polymers.
J Biol Chem
1998;273(46):
30069
e
74.
58. Mendeleyev J, Kirsten E, Hakam A, Buki KG, Kun E. Potential
chemotherapeutic activity of 4-iodo-3-nitrobenzamide. Metabolic
reduction to the 3-nitroso derivative and induction of cell death
in tumor cells in culture.
Biochem Pharmacol
1995;50(5):705
e
72.
41. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P,
et al. PARP-2, A novel mammalian DNA damage-dependent
poly(ADP-ribose) polymerase.
J Biol Chem
1999;274(25):17860
e
14.
59. Bauer PI, Mendeleyeva J, Kirsten E, Comstock JA, Hakam A,
Buki KG, et al. Anti-cancer action of 4-iodo-3-nitrobenzamide in
combination with buthionine sulfoximine: inactivation of poly
(ADP-ribose) polymerase and tumor glycolysis and the appear-
ance of a poly(ADP-ribose) polymerase protease.
Biochem Phar-
macol
2002;63(3):455
e
8.
42. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V, et al.
Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient
base excision DNA repair in association with PARP-1 and
XRCC1.
J Biol Chem
2002;277(25):23028
e
36.
43. Menissier de Murcia J, Ricoul M, Tartier L, Niedergang C,
Huber A, Dantzer F, et al. Functional interaction between PARP-1
and PARP-2 in chromosome stability and embryonic develop-
ment in mouse.
EMBO J
2003;22(9):2255
e
62.
60. Curtin N. Therapeutic potential of drugs to modulate DNA
repair in cancer.
Expert Opin Ther Targets
2007;11(6):783
e
99.
61. Drew Y, Calvert H. The potential of PARP inhibitors in genetic
breast and ovarian cancers.
Ann NY Acad Sci
2008;1138:136
e
63.
44. Masutani M, Nozaki T, Nakamoto K, Nakagama H, Suzuki H,
Kusuoka O, et al. The response of Parp knockout mice against
DNA damaging agents.
Mutat Res
2000;462(2-3):159
e
45.
62. Ferraris DV. Evolution of poly(ADP-ribose) polymerase-1
(PARP-1) inhibitors. From concept to clinic.
J Med Chem
2010;
53(12):4561
e
e
66.
e
84.
